MRKR - Marker Therapeutics GAAP EPS of -$0.12 beats by $0.01 revenue of $964.32M May, 13 2022 07:48 AM Marker Therapeutics Inc. Marker Therapeutics press release (NASDAQ:MRKR): Q1 GAAP EPS of -$0.12 beats by $0.01. Revenue of $964.32M. For further details see: Marker Therapeutics GAAP EPS of -$0.12 beats by $0.01, revenue of $964.32M